dexmedetomidine
Nervous system (N05)Nervous system (N05) compound in Shiyou Wei's portfolio. Mechanism: Adrenergic receptor alpha-2 agonist.
- Mechanism
- Adrenergic receptor alpha-2 agonist
pharma · Lung Cancer
Shiyou Wei
Shiyou Wei drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Shiyou Wei pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Shiyou Wei drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.